Stock

Protalix BioTherapeutics, Inc. PLX

$2.12+11.32%

All stocks Create account to unlock

Overview

PLX market data

Price History

PLX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for PLX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured

8-K filing — Protalix BioTherapeutics, Inc. (PLX) · May 21, 2026, 11:03 AM

CORRECTION: Protalix BioTherapeutics Q1 EPS $0.22 Beats $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate · May 13, 2026, 1:37 PM

Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call · May 13, 2026, 12:19 PM

Earnings Scheduled For May 13, 2026 · May 13, 2026, 11:11 AM

Protalix BioTherapeutics Q1 EPS $0.05 Misses $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate · May 13, 2026, 11:02 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock